West Pharmaceutical Services Inc. (NYSE:WST) Shares Sold by New York State Teachers Retirement System

New York State Teachers Retirement System reduced its position in West Pharmaceutical Services Inc. (NYSE:WST) by 9.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 95,950 shares of the medical instruments supplier’s stock after selling 10,389 shares during the period. New York State Teachers Retirement System’s holdings in West Pharmaceutical Services were worth $12,008,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Hoover Financial Advisors Inc. lifted its stake in shares of West Pharmaceutical Services by 0.3% in the 1st quarter. Hoover Financial Advisors Inc. now owns 42,208 shares of the medical instruments supplier’s stock valued at $4,651,000 after purchasing an additional 107 shares in the last quarter. Zions Bancorporation N.A. lifted its position in West Pharmaceutical Services by 3.0% during the 2nd quarter. Zions Bancorporation N.A. now owns 5,242 shares of the medical instruments supplier’s stock worth $656,000 after acquiring an additional 155 shares in the last quarter. Public Employees Retirement System of Ohio lifted its position in West Pharmaceutical Services by 0.4% during the 4th quarter. Public Employees Retirement System of Ohio now owns 42,374 shares of the medical instruments supplier’s stock worth $4,154,000 after acquiring an additional 159 shares in the last quarter. Crossmark Global Holdings Inc. lifted its position in West Pharmaceutical Services by 2.1% during the 1st quarter. Crossmark Global Holdings Inc. now owns 7,636 shares of the medical instruments supplier’s stock worth $841,000 after acquiring an additional 160 shares in the last quarter. Finally, Louisiana State Employees Retirement System lifted its position in West Pharmaceutical Services by 1.0% during the 1st quarter. Louisiana State Employees Retirement System now owns 19,900 shares of the medical instruments supplier’s stock worth $2,193,000 after acquiring an additional 200 shares in the last quarter. 91.62% of the stock is currently owned by institutional investors and hedge funds.

WST stock opened at $137.48 on Wednesday. The company has a quick ratio of 2.13, a current ratio of 2.88 and a debt-to-equity ratio of 0.19. West Pharmaceutical Services Inc. has a 52-week low of $91.75 and a 52-week high of $139.23. The business’s 50 day simple moving average is $124.45. The stock has a market cap of $10.10 billion, a P/E ratio of 48.93, a PEG ratio of 3.91 and a beta of 1.30.

West Pharmaceutical Services (NYSE:WST) last posted its quarterly earnings data on Thursday, July 25th. The medical instruments supplier reported $0.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.72 by $0.17. West Pharmaceutical Services had a return on equity of 17.15% and a net margin of 12.94%. The company had revenue of $469.70 million for the quarter, compared to the consensus estimate of $459.90 million. During the same period in the previous year, the business earned $0.70 EPS. West Pharmaceutical Services’s revenue for the quarter was up 5.0% compared to the same quarter last year. Equities research analysts anticipate that West Pharmaceutical Services Inc. will post 3.06 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 6th. Shareholders of record on Wednesday, October 23rd will be issued a dividend of $0.15 per share. The ex-dividend date of this dividend is Tuesday, October 22nd. This represents a $0.60 annualized dividend and a yield of 0.44%. West Pharmaceutical Services’s dividend payout ratio is presently 21.35%.

Several equities analysts recently commented on the company. Bank of America lowered Citigroup to a “hold” rating in a research report on Friday, July 26th. William Blair reissued an “outperform” rating on shares of bluebird bio in a research report on Tuesday, April 23rd. Jefferies Financial Group boosted their price target on EXACT Sciences from $100.00 to $115.00 and gave the stock a “buy” rating in a research report on Wednesday, May 1st. Finally, Zacks Investment Research lowered Inflarx from a “buy” rating to a “hold” rating in a research report on Friday, May 3rd. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. West Pharmaceutical Services presently has a consensus rating of “Hold” and a consensus target price of $123.05.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.

Read More: Diversification For Individual Investors

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.